Staphylococcus haemolyticus – an emerging threat in the twilight of the antibiotics age
Tóm tắt
Từ khóa
Tài liệu tham khảo
Billot-Klein, 1996, Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics, J Bacteriol, 178, 4696, 10.1128/jb.178.15.4696-4703.1996
Bochniarz, 2013, Resistance to methicillin of coagulase-negative staphylococci (CNS) isolated from bovine mastitis, Pol J Vet Sci, 16, 687, 10.2478/pjvs-2013-0097
Cercenado, 1996, Emergence of teicoplanin-resistant coagulase-negative staphylococci, J Clin Microbiol, 34, 1765, 10.1128/JCM.34.7.1765-1768.1996
Chambers, 1988, Methicillin-resistant staphylococci, Clin Microbiol Rev, 1, 173, 10.1128/CMR.1.2.173
Daniel, 2014, Significance of Staphylococcus haemolyticus in hospital acquired infections, J Pioneer Med Sci, 4, 119
Degener, 1994, Nosocomial infection by Staphylococcus haemolyticus and typing methods for epidemiological study, J Clin Microbiol, 32, 2260, 10.1128/JCM.32.9.2260-2265.1994
Eng, 1982, Species identification of coagulase-negative staphylococcal isolates from blood cultures, J Clin Microbiol, 15, 439, 10.1128/JCM.15.3.439-442.1982
Fajardo Olivares, 2011, Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia, Rev Esp Quimioter, 24, 74
Gemmell, 1982, Identification of coagulase-negative staphylococci with the API staph system, J Clin Microbiol, 16, 874, 10.1128/JCM.16.5.874-877.1982
Hope, 2008, Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001–06, J Antimicrob Chemother, 62, ii65
John, 2007, History and evolution of antibiotic resistance in coagulase-negative staphylococci: susceptibility profiles of new anti-staphylococcal agents, Ther Clin Risk Manag, 3, 1143
John, 1978, Species identification of coagulase-negative staphylococci from urinary tract isolates, J Clin Microbiol, 8, 435, 10.1128/jcm.8.4.435-437.1978
Kloos, 1975, Simplified scheme for routine identification of human Staphylococcus species, J Clin Microbiol, 1, 82, 10.1128/JCM.1.1.82-88.1975
Kollef, 2009, New antimicrobial agents for methicillin-resistant Staphylococcus aureus, Crit Care Resusc, 11, 282
Liekweg, 1977, Vascular prosthetic infections: collected experience and results of treatment, Surgery, 81, 335
Livermore, 2003, Linezolid in vitro: mechanism and antibacterial spectrum, J Antimicrob Chemother, 51, ii9
Młynarczyk, 2008, [Molecular mechanisms of resistance to antimicrobial agents in Staphylococcus aureus], Postępy Mikrobiol, 47, 423
Rahman, 2012, Species distribution of coagulase negative staphylococci isolated from different clinical specimens, Mymensingh Med J, 21, 195
Rajan, 2014, cfr-positive clinical staphylococcal isolate from India with multiple mechanisms of linezolid-resistance, Indian J Med Res, 139, 463
Rosenstein, 2013, What distinguishes highly pathogenic staphylococci from medium- and non-pathogenic?, Curr Top Microbiol Immunol, 358, 33
Sieradzki, 1998, Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci, Antimicrob Agents Chemother, 42, 100, 10.1128/AAC.42.1.100
Simango, 2005, Characterisation of Staphylococcus haemolyticus isolated from urinary tract infections, Cent Afr J Med, 51, 112
Squeri, 2012, Surveillance and evidence of contamination in hospital environment from meticillin and vancomycin-resistant microbial agents, J Prev Med Hyg, 53, 143
Sutherland, 1964, Characteristics of methicillin-resistant staphylococci, J Bacteriol, 87, 887, 10.1128/JB.87.4.887-899.1964
Szczuka, 2014, [The diversity of SCCmec cassettes with methicillin-resistant coagulase-negative staphylococci], Post Mikrobiol, 53, 223
Veach, 1990, Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection, J Clin Microbiol, 28, 2064, 10.1128/JCM.28.9.2064-2068.1990
Vos, 2009, Bergey's Manual of Systematic Bacteriology